# Bolt Biotherapeutics, Inc.: filings

BOLT · Nasdaq · CIK 1641281 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bolt.md) · [Financials](/companies/bolt/financials.md) · [Filings](/companies/bolt/filings.md) · [Insiders](/companies/bolt/insiders.md)

## Reports and events: 90 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 110, 8-K 46, 3 22, 10-Q 17, SC 13G/A 8, 5 7, D 7, SC 13D/A 7, 10-K 6, DEF 14A 6, S-8 6, DEFA14A 5, SC 13G 5, SCHEDULE 13G/A 5, ARS 4, CORRESP 4, SC 13D 3, UPLOAD 3, DRS/A 2, DRSLTR 2, EFFECT 2, S-1/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, DRS 1, PRE 14A 1, S-1 1, S-1MEF 1, S-3 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 10:31 ET | [8-K](/filings/0001193125-26-429647.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429647 |
| 2026-10-06 | 16:07 ET | [8-K](/filings/0001193125-26-415560.md) | 1.01 Entry into a material agreement | 0001193125-26-415560 |
| 2026-08-11 | 16:06 ET | [10-Q](/filings/0001193125-26-344597.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344597 |
| 2026-08-11 | 16:05 ET | [8-K](/filings/0001193125-26-344580.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344580 |
| 2026-06-11 | 16:05 ET | [8-K](/filings/0001193125-26-267487.md) | 5.07 Shareholder vote results | 0001193125-26-267487 |
| 2026-05-12 | 16:06 ET | [10-Q](/filings/0001193125-26-219382.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219382 |
| 2026-05-12 | 16:05 ET | [8-K](/filings/0001193125-26-219361.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219361 |
| 2026-04-28 | 16:05 ET | [DEF 14A](/filings/0001193125-26-186923.md) | Proxy statement, period 2026-04-27 | 0001193125-26-186923 |
| 2026-03-12 | 16:07 ET | [10-K](/filings/0001193125-26-104121.md) | Annual report, period 2025-12-31 | 0001193125-26-104121 |
| 2026-03-12 | 16:05 ET | [8-K](/filings/0001193125-26-104102.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104102 |
| 2026-02-26 | 19:22 ET | [SCHEDULE 13D/A](/filings/0001012975-26-000212.md) | Ownership report, active investor, amended | 0001012975-26-000212 |
| 2026-02-17 | 20:11 ET | [SCHEDULE 13D/A](/filings/0001012975-26-000173.md) | Ownership report, active investor, amended | 0001012975-26-000173 |
| 2025-11-12 | 16:08 ET | [10-Q](/filings/0001193125-25-277549.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277549 |
| 2025-11-12 | 16:05 ET | [8-K](/filings/0001193125-25-277521.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277521 |
| 2025-10-02 | 16:05 ET | [8-K](/filings/0001193125-25-228293.md) | 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-25-228293 |
| 2025-08-14 | 16:09 ET | [10-Q](/filings/0001641281-25-000007.md) | Quarterly report, period 2025-06-30 | 0001641281-25-000007 |
| 2025-08-14 | 16:05 ET | [8-K](/filings/0001641281-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641281-25-000006 |
| 2025-06-06 | 16:39 ET | [8-K](/filings/0000950170-25-083180.md) | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws | 0000950170-25-083180 |
| 2025-06-04 | 16:05 ET | [8-K](/filings/0000950170-25-081607.md) | 8.01 Other events | 0000950170-25-081607 |
| 2025-05-28 | 17:41 ET | [8-K](/filings/0000950170-25-077880.md) | 5.07 Shareholder vote results | 0000950170-25-077880 |
| 2025-05-12 | 16:08 ET | [10-Q](/filings/0000950170-25-069188.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069188 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0000950170-25-069153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069153 |
| 2025-04-25 | 15:48 ET | [DEF 14A](/filings/0000950170-25-058632.md) | Proxy statement, period 2025-05-27 | 0000950170-25-058632 |
| 2025-04-16 | 17:22 ET | [8-K](/filings/0000950170-25-054871.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-054871 |
| 2025-04-15 | 16:39 ET | [DEF 14A](/filings/0000950170-25-054294.md) | Proxy statement, period 2025-05-27 | 0000950170-25-054294 |
| 2025-03-24 | 16:26 ET | [10-K](/filings/0000950170-25-043873.md) | Annual report, period 2024-12-31 | 0000950170-25-043873 |
| 2025-03-24 | 16:25 ET | [8-K](/filings/0000950170-25-043869.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-043869 |
| 2025-01-03 | 16:10 ET | [8-K](/filings/0000950170-25-001159.md) | 3.01 Delisting notice | 0000950170-25-001159 |
| 2024-12-23 | 16:10 ET | [8-K](/filings/0000950170-24-139580.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-139580 |
| 2024-11-12 | 16:14 ET | [10-Q](/filings/0000950170-24-125413.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125413 |
| 2024-11-12 | 16:09 ET | [8-K](/filings/0000950170-24-125376.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125376 |
| 2024-09-04 | 17:38 ET | [8-K](/filings/0001193125-24-213225.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-213225 |
| 2024-08-13 | 16:10 ET | [10-Q](/filings/0000950170-24-096200.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096200 |
| 2024-08-13 | 16:08 ET | [8-K](/filings/0000950170-24-096191.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096191 |
| 2024-07-03 | 17:19 ET | [8-K](/filings/0001193125-24-175113.md) | 3.01 Delisting notice | 0001193125-24-175113 |
| 2024-06-14 | 13:15 ET | [8-K](/filings/0000950170-24-073501.md) | 5.07 Shareholder vote results | 0000950170-24-073501 |
| 2024-05-14 | 16:14 ET | [10-Q](/filings/0000950170-24-059564.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059564 |
| 2024-05-14 | 16:06 ET | [8-K](/filings/0000950170-24-059524.md) | 2.01 Completion of an acquisition or disposition; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-059524 |
| 2024-04-26 | 16:06 ET | [DEF 14A](/filings/0000950170-24-049095.md) | Proxy statement, period 2024-06-12 | 0000950170-24-049095 |
| 2024-03-21 | 16:10 ET | [10-K](/filings/0000950170-24-034692.md) | Annual report, period 2023-12-31 | 0000950170-24-034692 |
| 2024-03-21 | 16:08 ET | [8-K](/filings/0000950170-24-034688.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034688 |
| 2024-02-12 | 21:41 ET | [SC 13D/A](/filings/0001193125-24-032572.md) | Ownership report, active investor, amended | 0001193125-24-032572 |
| 2023-11-09 | 16:10 ET | [10-Q](/filings/0000950170-23-062048.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062048 |
| 2023-11-09 | 16:08 ET | [8-K](/filings/0000950170-23-062027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062027 |
| 2023-08-07 | 16:08 ET | [10-Q](/filings/0000950170-23-039061.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039061 |
| 2023-08-07 | 16:06 ET | [8-K](/filings/0000950170-23-039047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039047 |
| 2023-06-13 | 16:55 ET | [8-K](/filings/0000950170-23-027743.md) | 5.07 Shareholder vote results | 0000950170-23-027743 |
| 2023-05-11 | 16:11 ET | [10-Q](/filings/0000950170-23-021233.md) | Quarterly report, period 2023-03-31 | 0000950170-23-021233 |
| 2023-05-11 | 16:09 ET | [8-K](/filings/0000950170-23-021225.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021225 |
| 2023-04-28 | 16:09 ET | [DEF 14A](/filings/0000950170-23-015790.md) | Proxy statement, period 2023-06-12 | 0000950170-23-015790 |

Page 1 of 2. [Older](/companies/bolt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:22 ET. No prices; not investment advice.